share_log

5 Cheapest Health Care Stocks You Should Think About

5 Cheapest Health Care Stocks You Should Think About

你应该考虑的 5 只最便宜的医疗保健股
Benzinga Real-time News ·  2023/01/27 08:51

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

医疗保健领域超卖次数最多的股票为买入被低估的公司提供了机会。

The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30.

RSI是一种动量指标，它比较了股票在价格上涨的日子里的强度与价格下跌时的强度。与股票的价格走势相比，它可以让交易者更好地了解股票在短期内的表现。当 RSI 低于 30 时，资产通常被视为超卖。

Here's the latest list of major oversold players in this sector, having an RSI near or below 30.

以下是该行业主要超卖参与者的最新名单，RSI接近或低于30。

Third Harmonic Bio, Inc. (NASDAQ:THRD)

第三谐波生物有限公司 （纳斯达克股票代码：THRD）

  • Third Harmonic Bio, last month, announced discontinuation of its Phase 1b study of THB001 in chronic inducible urticaria.. The company's stock has a 52-week low of $3.89 .
  • RSI Value: 28.67
  • THRD Price Action: Shares of Third Harmonic Bio settled at $4.25 on Thursday and added 6.4% in after-hours trading.
  • Third Harmonic Bio 上个月宣布终止其针对慢性诱发性荨麻疹 THB001 的 1b 期研究。该公司的股票有 52 周低点 3.89 美元 。
  • RSI 值： 28.67
  • THRD 价格走势： Third Harmonic Bio的股价周四收于4.25美元，盘后交易中上涨了6.4％。

Bio-Techne Corporation (NASDAQ:TECH)

生物技术公司 （纳斯达克：科技）

  • Wells Fargo recently upgraded the stock from Underweight to Equal-Weight. The company's stock has a 52-week low of $68.00.
  • RSI Value: 29.19
  • TECH Price Action: Shares of Bio-Techne rose 0.6% to close at $80.32 on Thursday.
  • 富国银行最近将股票从 “减持” 上调至 “同等权重”。该公司的 股票创下 52 周低点 68.00 美元。
  • RSI 值： 29.19
  • 科技价格走势： 周四，Bio-Techne的股价上涨0.6％，收于80.32美元。

AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. （纽约证券交易所代码：ABBV）

  • Piper Sandler recently maintained AbbVie with an Overweight and raised the price target from $155 to $157.. The company's stock has a 52-week low of $133.05.
  • RSI Value: 28.94
  • ABBV Price Action: Shares of AbbVie fell 0.3% to close at $147.40 on Thursday and added 0.2% in after-hours trading.
  • 派珀·桑德勒最近维持了艾伯维的增持，并将目标股价从155美元上调至157美元。该公司的股票有52周的股票 低点为133.05美元。
  • RSI 值： 28.94
  • ABBV 价格走势： 周四，AbbVie的股价下跌0.3％，收于147.40美元，盘后交易中上涨了0.2％。

1Life Healthcare, Inc. (NASDAQ:ONEM)

1Life Healthcare （纳斯达克股票代码：ONEM）

  • 1Life Healthcare, during November, posted a Q3 loss of $0.57 per share. The company's 52-week low is $5.94.
  • RSI Value: 29.09
  • ONEM Price Action: Shares of 1Life Healthcare fell 0.7% to close at 15.98 on Thursday and lost 0.8% in after-hours trading.
  • 1Life Healthcare，在 公布了第三季度的亏损 每股0.57美元。该公司的52周低点为5.94美元。
  • RSI 值： 29.09
  • ONEM 价格走势： 周四，1Life Healthcare的股价下跌0.7％，收于15.98，盘后交易中下跌0.8％。

Fate Therapeutics, Inc. (NASDAQ:FATE)

Fate Therapeutics, （纳斯达克股票代码：FATE）

  • HC Wainwright & Co. downgraded Fate Therapeutics from Buy to Neutral and lowered the price target from $115 to $7. The company has a 52-week low of $4.02.
  • RSI Value: 24.79
  • FATE Price Action: Shares of Fate Therapeutics fell 1.9% to close at $5.30 on Thursday and lost 1.3% in after-hours trading.
  • HC Wainwright & Co. 将Fate Therapeutics的评级从买入下调至中性，并将目标价从115美元下调至7美元。该公司 创下 52 周低点 的 4.02 美元。
  • RSI 值： 24.79
  • FATE 价格走势： 周四，Fate Therapeutics的股价下跌了1.9％，收于5.30美元，盘后交易中下跌了1.3％。

Read More: Investor Optimism Improves Further Following GDP Report

阅读更多： GDP报告发布后，投资者乐观情绪进一步改善

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发